Prediction of clinically insignificant prostate cancer by detection of allelic imbalance at 6q, 8p and 13q

Pathology International

Volumn 58, Issue 7, 2008, Pages 415-420

  Nakano, Masataka ^a   Takahashi, Hiroyuki ^a   Shiraishi, Taizo ^b   Lu, Tomoe ^a   Furusato, Masakuni ^a   Wakui, Shin ^a   Hano, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Insignificant cancer; Loss of heterozygosity; Prostate cancer; Tumor volume

Indexed keywords

ADULT; AGED; ALLELE; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; GENE FREQUENCY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR VOLUME;

AGED; ALLELIC IMBALANCE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 44949126350     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02246.x     Document Type: Article

References (28)

1. Ministry of Health, Labor and Welfare. Annual Reports of Cancer Incidence. Tokyo : Ministry of Health, Labor and Welfare, 2001.
2. Furuya Y, Fuse H, Nagakawa O et al. Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer. Int J Clin Oncol 2002 7 : 109 13.
3. Soh S, Kattan MW, Berkman S et al. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 1997 157 : 2212 18.
4. Meng MV, Elkin EP, DuChane J et al. Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol 2006 176 : 63 9.
5. Epstein JI, Walsh PC, Carmichael M et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994 271 : 368 74.
6. Kabalin JN, McNeal JE, Price HM et al. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: Incidence, histology and morphometric observations. J Urol 1989 141 : 1091 4.
7. Yatani R, Shiraishi T, Nakakuki K et al. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 1988 80 : 683 7.
8. Stamey TA, Freiha FS, McNeal JE et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993 71 : 933 8.
9. Goldstein NS, Begin LR, Grody WW et al. Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the 'vanishing cancer phenomenon'. Am J Surg Pathol 1995 19 : 1002 9.
10. Cheng L, Poulos CK, Pan CX et al. Preoperative prediction of small volume cancer (less than 0.5 mL) in radical prostatectomy specimens. J Urol 2005 174 : 898 902.
11. Noguchi M, Stamey TA, McNeal JE et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001 166 : 104 9.
12. Steinberg GD, Bales GT, Brendler CB. An analysis of watchful waiting for clinically localized prostate cancer. J Urol 1998 159 : 1431 6.
13. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005 352 : 1977 84.
14. Ogawa O, Egawa S, Arai Y et al. Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol 1998 5 : 454 8.
15. Cupp MR, Bostwick DG, Myers RP et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 1995 153 : 1543 8.
16. Ravery V, Szabo J, Toublanc M et al. A single positive prostate biopsy in six does not predict a low-volume prostate tumour. Br J Urol 1996 77 : 724 8.
17. Terris MK, McNeal JE, Stamey TA. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 1992 147 : 855 7.
18. Coakley FV, Kurhanewicz J, Lu Y et al. Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002 223 : 91 7.
19. Lu W, Takahashi H, Furusato B et al. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers. Genes Chromosomes Cancer 2006 45 : 509 15.
20. Lu W, Takahashi H, Furusato M et al. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers. Prostate 2006 66 : 405 12.
21. Ruijter ET, Miller GJ, van de Kaa CA et al. Molecular analysis of multifocal prostate cancer lesions. J Pathol 1999 188 : 271 7.
22. Alers JC, Krijtenburg PJ, Vis AN et al. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: Early cancers may contain aggressive genetic features. Am J Pathol 2001 158 : 399 406.
23. Cooney KA, Wetzel JC, Consolino CM et al. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res 1996 56 : 4150 53.
24. MacGrogan D, Levy A, Bostwick D et al. Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromosomes Cancer 1994 10 : 151 9.
25. Perinchery G, Bukurov N, Nakajima K et al. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. Int J Oncol 1999 14 : 495 500.
26. Dong JT, Boyd JC, Frierson HF Jr. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 2001 49 : 166 71.
27. Cooney KA, Wetzel JC, Merajver SD et al. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 1996 56 : 1142 5.
28. Afonso A, Emmert-Buck MR, Duray PH et al. Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol 1999 162 : 922 6.